0001213900-23-100063.txt : 20231229
0001213900-23-100063.hdr.sgml : 20231229
20231229171733
ACCESSION NUMBER: 0001213900-23-100063
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231228
FILED AS OF DATE: 20231229
DATE AS OF CHANGE: 20231229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SETH SANDESH
CENTRAL INDEX KEY: 0001566175
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36374
FILM NUMBER: 231528616
MAIL ADDRESS:
STREET 1: 300 E 93RD STREET, #20-B
CITY: NEW YORK
STATE: NY
ZIP: 10128
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Actinium Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001388320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 880378336
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 PARK AVE., 23RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: (646) 677-3870
MAIL ADDRESS:
STREET 1: 100 PARK AVE., 23RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER COMPANY:
FORMER CONFORMED NAME: Cactus Ventures, Inc.
DATE OF NAME CHANGE: 20070130
4
1
ownership.xml
X0508
4
2023-12-28
0
0001388320
Actinium Pharmaceuticals, Inc.
ATNM
0001566175
SETH SANDESH
C/O ACTINIUM PHARMACEUTICALS,
INC., 100 PARK AVE., 23RD FLOOR
NEW YORK
NY
10017
1
1
0
0
Chief Executive Officer
0
Stock Option (Right to Buy)
5.00
2023-12-28
4
A
0
984367
0
A
2033-12-28
Common Stock
984367
984367
D
This price represents the closing price of the Issuer's common stock on December 28, 2023, the date of the grant.
Pursuant to the terms of the Issuer's 2019 Stock Plan, 2% of the options will vest each month from the date of grant until fully vested.
/s/ Sandesh Seth
2023-12-29